We won’t overcharge you through a subscription model. Our one off economical prices remain fixed all the time

Clinician-led weight management for  Non-Alcoholic Fatty Liver Disease.

NAFLD affects 1 in 3 UK adults and clinician-managed weight loss is the primary evidence-based intervention. Our GLP-1 specialists design a medicated programme around your liver health.

Takes 5 minutes
· No commitment · Reviewed within 1 working day

photo 1571019613454 1cb2f99b2d8b
Programme members
7–10%
weight loss can resolve fatty liver
Ellipse 276 3
Ellipse 275 (3)
Ellipse 274 (4)
Non-Alcoholic Fatty Liver Disease
Ellipse 276 3
1 in 3

UK adults estimated to have NAFLD at some stage

NAFLD is the most common liver condition in the UK. It is largely silent, rarely symptomatic, and closely linked to excess weight. Clinician-managed weight loss is the primary proven intervention.

Source: British Liver Trust, 2024 · View source ↗

The Challenge

NAFLD is silent, progressive — and clinician-managed weight loss is the proven intervention

NAFLD has no symptoms until it becomes serious liver damage

Most people with NAFLD feel no symptoms until the condition has progressed to NASH or fibrosis. By then, liver damage is established. The window for reversal through clinician-managed weight loss is earlier — and requires specialist oversight to achieve.
📖 NICE Guideline NG49 — Non-alcoholic fatty liver disease, 2016

There is no approved medication for NAFLD — weight management is the treatment

Unlike many chronic conditions, NAFLD has no licensed pharmacological treatment. NICE and international liver societies consistently identify clinician-managed weight loss as the primary intervention. GLP-1 medication provides the clinical tool to achieve the 7–10% threshold.
📖 European Association for the Study of the Liver (EASL) — NAFLD Guidelines, 2023

Long waits can delay progress

When weight is affecting your health, waiting months for support can feel frustrating. WeightFall gives you faster access to clinician-led weight management, starting with a review within 1 working day
📖 NHS England Referral to Treatment Data, Q3 2024
7–10%
Ellipse 655

body weight reduction resolves fatty liver in the majority of NAFLD patients

📖 EASL Clinical Practice Guidelines — NAFLD, 2023
30%
Ellipse 655

of UK adults estimated to have NAFLD — rising to 75% in people with obesity

📖 British Liver Trust, 2024

NHS specialist support can take time

📖 NHS England, Referral to Treatment Statistics, 2024-
Ellipse 655 (1)
Ellipse 656 (1)

No need for subscriptions,

get weight management programme through us for the lowest price
The Programme Approach

A clinician-managed
programme built around your condition

WeightFall combines GLP-1 medication with specialist clinical oversight a managed programme, not just a prescription service.
Clinician-prescribed · Condition-aware

Medicated Weight Management

GLP-1 medication assessed and prescribed by your GLP-1 specialist clinician, with dose titration specifically calibrated to your diabetes medication history, blood sugar control, and health profile.
01
Regular · Adaptive · Ongoing

3-Weekly Clinician Check-ins

Your dedicated GLP-1 specialist reviews your progress every 3 weeks — adjusting your dose, managing side effects, and evolving your plan as you respond. Not a one-off consultation.
02
Food · Movement · Mindset

Lifestyle & Habit Guidance

Food, movement, sleep and mindset coaching alongside your medication — with specific guidance on managing blood sugar through lifestyle, not just medication.
03
GLP-1 specialist clinicians · Reviewed within 1 working day
Member Stories

Real people, Verified outcomes

Condition-specific health metrics — not just numbers on a scale.
Takes 5 minutes · No commitment · Reviewed within 1 working day
The WeightFall Programme

Everything included — from £85/month

Every WeightFall programme includes the same level of clinical oversight, support and monitoring — regardless of which treatment your clinician recommends.

Clinical assessment & review

Your case reviewed by a GLP-1 specialist clinician before treatment begins. Condition-specific. Thorough. Personal.

Check-in every 3 weeks

Regular clinician review of your progress, dose and side effects. You’re never left to figure it out between appointments.

Dose adjustment support

Your plan adapts as you respond to treatment — no fixed templates. Dose escalation managed by your specialist throughout.

Lifestyle & habit guidance

Food, movement, sleep and mindset coaching alongside your treatment. Sustainable change, not just medication.

Fully online — no GP referral

Everything managed from home. A UK-registered clinician reviews your case and responds within 1 working day. Completely private.

Secure & confidential

Your health data handled with full clinical confidentiality. GDPR compliant. Secure encrypted platform.
Individual results vary. Data based on published clinical trial evidence. Your clinician will set realistic expectations for your specific case at assessment.

Your weight management journey

Week 1–4
Programme begins
Clinician reviews your case, dosing starts. First check-in at week 3. Most patients notice reduced appetite early on.
Month 1–3
Early progress
Appetite changes become more consistent. Dose adjusted as needed.
Month 3–6
Meaningful change
Progressive dose increases. Body weight reduction. Lifestyle coaching integrated alongside medication.
Month 6–12
Sustained results
Clinical trial shows body weight reduction. Clinician guides maintenance or tapering.
Programmes from
£85/month
Price varies by treatment type and dose. Your clinician confirms before any commitment.
If you’re not clinically eligible, you won’t be charged for treatment.

Evidence-based. Peer-reviewed. Regulated.

Every element of the WeightFall programme is grounded in clinical evidence. Our approach is informed by the highest-quality published studies — and updated as new evidence emerges.
01
EASL Clinical Practice Guidelines — NAFLD, 2023
EASL guidelines confirm a minimum 7–10% weight loss as the primary evidence-based intervention for NAFLD, with improvement in liver histology at this threshold.
02
Promrat K et al. — Hepatology, 2010
RCT: ≥7% weight loss was associated with significant improvement in liver histology in overweight patients with NASH.
03
Romero-Gómez M et al. — J Hepatology, 2017
Review confirming the role of dietary fructose, refined carbohydrates, and calorie excess in NAFLD pathogenesis — and the importance of clinician-managed weight loss.

Regulatory statement (CAP Code 12.1): WeightFall is a clinician-led weight management service. All treatments are prescription-only and subject to clinical assessment by UK- registered clinicians. WeightFall does not diagnose, treat, or cure any medical condition. Clinicians are registered with the General Medical Council (GMC). This service is not a substitute for NHS care.

Your questions, answered

Condition-specific answers — straight from our clinical team.

Find Out If You're Eligible

We’ll ask you a few quick questions to help determine your eligibility for treatment. Your responses will remain private and confidential.
Frame 1321315189 1
Is this a medical treatment for NAFLD?
No. WeightFall provides clinician-led medicated weight management. It does not treat NAFLD. Some patients see improvements in liver markers — but this is not guaranteed and varies individually.
No — individual results vary significantly. No specific liver or health outcome is guaranteed.
We cannot make this claim. Clinical evidence shows significant liver improvement in many people who achieve ≥7–10% weight loss — but individual responses vary. Your clinician will set realistic expectations at assessment.
No. You can join based on a clinical diagnosis or GP concern. Having recent liver function tests (LFTs) is helpful but not mandatory to begin the eligibility check.
Every 3 weeks your GLP-1 specialist clinician reviews your progress, weight, side effects, and any available liver markers. Fully online.
With your consent, we will notify your GP about the initiation of your weight management treatment.
If a clinician determines treatment isn’t appropriate, your payment for that order is refunded.
First treatment dose, clinical assessment review, clinician sign-off, and first 3-weekly check-in. Prices vary by treatment type and dose — full breakdown before commitment.
No. Treatment is reviewed continuously. Your clinician guides you on tapering if you choose to stop.
Yes. WeightFall is a private programme running alongside NHS hepatology or gastroenterology care. Maintain all NHS appointments.
Yes. Our UK-registered clinicians assess your suitability independently based on your health history, BMI, and relevant conditions.